2025-2029年全球血糖監測系統市場

全球血糖值監測系統市場預估在2024年至2029年間成長101.4億美元，預測期內複合年成長率（CAGR）為10.0%。本報告對全球血糖值監測系統市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約25家公司的供應商分析。

該報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的促進因素包括血糖值監測設備報銷政策的實施、糖尿病患者數量的成長以及新產品發布數量的增加。

本研究採用客觀的方法，結合一手和二手資料，並參考了主要行業相關人員的意見。報告分析了主要企業，提供了全面的市場規模數據、區域細分市場分析以及供應商格局。報告同時提供了歷史數據和預測數據。

研究指出，對持續血糖監測（CGM）設備日益成長的需求是未來幾年推動全球血糖監測系統市場成長的主要因素之一。此外，捆綁式產品行銷策略的日益普及和策略發展的不斷推進預計也將顯著提升市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 價格、生命週期、顧客購買籃、採用率和購買標準分析
• 投入與差異化因素的重要性
• 混淆來源
• 促進因素和挑戰的影響

第3章 市場情勢

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場定義
• 市場區隔分析
• 2024年市場規模
• 2024-2029年市場展望

第5章 市場規模表現

• 2019-2023年全球血糖監測系統市場
• 2019-2023年產品細分市場分析
• 2019-2023年最終用戶細分市場分析
• 適應症細分市場分析 2019-2023
• 2019-2023年區域細分市場分析
• 2019-2023年國家細分市場分析

第6章 定性分析

• 人工智慧對全球血糖監測系統市場的影響

第7章五力分析

• 五力分析概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章 按產品進行市場細分

• 比較：按產品
• 自測血糖
• 連續血糖監測設備
• 按產品分類的市場機會

9. 按最終用戶進行市場區隔

• 比較：按最終用戶
• 醫院
• 居家醫療
• 診斷中心
• 按最終用戶分類的市場機會

第10章 依適應症進行市場細分

• 比較：依指示
• 2型糖尿病患者人數
• 1型糖尿病患者人數
• 按適應症分類的市場機會

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 荷蘭
  • 西班牙
• 亞洲
  • 日本
  • 中國
  • 印度
  • 韓國
  • 印尼
• 世界其他地區
  • 澳洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 以色列
  • 土耳其
• 各區域的市場機遇

第13章：促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 令人困惑的局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 企業排名指數
• 公司市場定位
• Abbott Laboratories
• ARKRAY Inc.
• B.Braun SE
• Dexcom Inc.
• F. Hoffmann La Roche Ltd.
• i-SENS, Inc.
• Indigo Diabetes NV
• Intuity Medical Inc.
• Koninklijke Philips NV
• LifeScan IP Holdings LLC
• Medtronic Plc
• Nipro Corp.
• PHC Holdings Corp.
• Prodigy Diabetes Care LLC
• Ypsomed Holding AG

第16章附錄

The global blood glucose monitoring system market is forecasted to grow by USD 10140.0 mn during 2024-2029, accelerating at a CAGR of 10.0% during the forecast period. The report on the global blood glucose monitoring system market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by availability of reimbursement for bgm devices, growing prevalence of diabetes, increasing number of product launches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global blood glucose monitoring system market is segmented as below:

By Product

• Self monitoring
• Continuous glucose monitoring devices

By End-User

• Hospitals
• Home care
• Diagnostic centers

By Indication

• Type-2 diabetes population
• Type-1 diabetes population

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the rising demand for continuous blood glucose monitoring (cgm) devices as one of the prime reasons driving the global blood glucose monitoring system market growth during the next few years. Also, increased adoption of bundled product marketing strategy and growing number of strategic developments will lead to sizable demand in the market.

The report on the global blood glucose monitoring system market covers the following areas:

• Global blood glucose monitoring system market sizing
• Global blood glucose monitoring system market forecast
• Global blood glucose monitoring system market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global blood glucose monitoring system market vendors that include Abbott Laboratories, ACON Laboratories Inc., ARKRAY Inc., B.Braun SE, Dexcom Inc., DiaMonTech AG, F. Hoffmann La Roche Ltd., GlySens Inc., i-SENS, Inc., Indigo Diabetes NV, Intuity Medical Inc., Koninklijke Philips NV, LifeScan IP Holdings LLC, Medtronic Plc, Nipro Corp., Ok Biotech Co Ltd., PHC Holdings Corp., Prodigy Diabetes Care LLC, WaveForm Technologies Inc., Ypsomed Holding AG. Also, the global blood glucose monitoring system market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Indication
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029

5 Historic Market Size

• 5.1 Global Blood Glucose Monitoring System Market 2019 - 2023
  • Historic Market Size - Data Table on Global Blood Glucose Monitoring System Market 2019 - 2023 ($ million)
• 5.2 Product segment analysis 2019 - 2023
  • Historic Market Size - Product Segment 2019 - 2023 ($ million)
• 5.3 End-user segment analysis 2019 - 2023
  • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
• 5.4 Indication segment analysis 2019 - 2023
  • Historic Market Size - Indication Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on the global blood glucose monitoring system market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Self monitoring - Market size and forecast 2024-2029
• 8.4 Continuous glucose monitoring devices - Market size and forecast 2024-2029
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2024-2029
• 9.4 Home care - Market size and forecast 2024-2029
• 9.5 Diagnostic centers - Market size and forecast 2024-2029
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Indication

• 10.1 Market segments
• 10.2 Comparison by Indication
• 10.3 Type-2 diabetes population - Market size and forecast 2024-2029
• 10.4 Type-1 diabetes population - Market size and forecast 2024-2029
• 10.5 Market opportunity by Indication
  • Market opportunity by Indication ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • 12.3.1 US - Market size and forecast 2024-2029
  • 12.3.2 Canada - Market size and forecast 2024-2029
  • 12.3.3 Mexico - Market size and forecast 2024-2029
• 12.4 Europe - Market size and forecast 2024-2029
  • 12.4.1 Germany - Market size and forecast 2024-2029
  • 12.4.2 UK - Market size and forecast 2024-2029
  • 12.4.3 France - Market size and forecast 2024-2029
  • 12.4.4 Italy - Market size and forecast 2024-2029
  • 12.4.5 The Netherlands - Market size and forecast 2024-2029
  • 12.4.6 Spain - Market size and forecast 2024-2029
• 12.5 Asia - Market size and forecast 2024-2029
  • 12.5.1 Japan - Market size and forecast 2024-2029
  • 12.5.2 China - Market size and forecast 2024-2029
  • 12.5.3 India - Market size and forecast 2024-2029
  • 12.5.4 South Korea - Market size and forecast 2024-2029
  • 12.5.5 Indonesia - Market size and forecast 2024-2029
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • 12.6.1 Australia - Market size and forecast 2024-2029
  • 12.6.2 Brazil - Market size and forecast 2024-2029
  • 12.6.3 Argentina - Market size and forecast 2024-2029
  • 12.6.4 Colombia - Market size and forecast 2024-2029
  • 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
  • 12.6.6 UAE - Market size and forecast 2024-2029
  • 12.6.7 South Africa - Market size and forecast 2024-2029
  • 12.6.8 Israel - Market size and forecast 2024-2029
  • 12.6.9 Turkey - Market size and forecast 2024-2029
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Availability of reimbursement for BGM devices
  • Growing prevalence of diabetes
  • Increasing number of product launches
• 13.2 Market challenges
  • Lower diagnosis and treatment rate
  • High cost of blood glucose monitoring systems and supplies
  • Intense competition among companies
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities
  • Rising demand for continuous blood glucose monitoring (CGM) devices
  • Increased adoption of bundled product marketing strategy
  • Growing number of strategic developments

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 ARKRAY Inc.
  • ARKRAY Inc. - Overview
  • ARKRAY Inc. - Product / Service
  • ARKRAY Inc. - Key offerings
  • SWOT
• 15.6 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key news
  • B.Braun SE - Key offerings
  • SWOT
• 15.7 Dexcom Inc.
  • Dexcom Inc. - Overview
  • Dexcom Inc. - Product / Service
  • Dexcom Inc. - Key offerings
  • SWOT
• 15.8 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.9 i-SENS, Inc.
  • i-SENS, Inc. - Overview
  • i-SENS, Inc. - Product / Service
  • i-SENS, Inc. - Key offerings
  • SWOT
• 15.10 Indigo Diabetes NV
  • Indigo Diabetes NV - Overview
  • Indigo Diabetes NV - Product / Service
  • Indigo Diabetes NV - Key offerings
  • SWOT
• 15.11 Intuity Medical Inc.
  • Intuity Medical Inc. - Overview
  • Intuity Medical Inc. - Product / Service
  • Intuity Medical Inc. - Key offerings
  • SWOT
• 15.12 Koninklijke Philips NV
  • Koninklijke Philips NV - Overview
  • Koninklijke Philips NV - Business segments
  • Koninklijke Philips NV - Key news
  • Koninklijke Philips NV - Key offerings
  • Koninklijke Philips NV - Segment focus
  • SWOT
• 15.13 LifeScan IP Holdings LLC
  • LifeScan IP Holdings LLC - Overview
  • LifeScan IP Holdings LLC - Product / Service
  • LifeScan IP Holdings LLC - Key offerings
  • SWOT
• 15.14 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.15 Nipro Corp.
  • Nipro Corp. - Overview
  • Nipro Corp. - Business segments
  • Nipro Corp. - Key offerings
  • Nipro Corp. - Segment focus
  • SWOT
• 15.16 PHC Holdings Corp.
  • PHC Holdings Corp. - Overview
  • PHC Holdings Corp. - Business segments
  • PHC Holdings Corp. - Key offerings
  • PHC Holdings Corp. - Segment focus
  • SWOT
• 15.17 Prodigy Diabetes Care LLC
  • Prodigy Diabetes Care LLC - Overview
  • Prodigy Diabetes Care LLC - Product / Service
  • Prodigy Diabetes Care LLC - Key offerings
  • SWOT
• 15.18 Ypsomed Holding AG
  • Ypsomed Holding AG - Overview
  • Ypsomed Holding AG - Business segments
  • Ypsomed Holding AG - Key offerings
  • Ypsomed Holding AG - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations